Cargando…

Inhibition of histone deacetylase 2 reduces MDM2 expression and reduces tumor growth in dedifferentiated liposarcoma

Dedifferentiated liposarcoma (DDLPS) is a highly morbid mesenchymal tumor characterized and driven by genomic amplification of the MDM2 gene. Direct inhibition of MDM2 has shown promise pre-clinically, but has yet to be validated in clinical trials. Early in vitro studies have demonstrated that pan-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seligson, Nathan D., Stets, Colin W., Demoret, Bryce W., Awasthi, Achal, Grosenbacher, Nicholas, Shakya, Reena, Hays, John L., Chen, James L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779286/ https://www.ncbi.nlm.nih.gov/pubmed/31620242 http://dx.doi.org/10.18632/oncotarget.27144

Ejemplares similares

MDM2-Dependent Rewiring of Metabolomic and Lipidomic Profiles in Dedifferentiated Liposarcoma Models
por: Patt, Andrew, et al.
Publicado: (2020)

Loss of TXNIP enhances peritoneal metastasis and can be abrogated by dual TORC1/2 inhibition
por: Spaeth-Cook, Douglas, et al.
Publicado: (2018)

Targeting the MDM2-p53 pathway in dedifferentiated liposarcoma
por: Traweek, Raymond S., et al.
Publicado: (2022)

Intraperitoneal dedifferentiated liposarcoma showing MDM2 amplification: case report
por: Grifasi, Carlo, et al.
Publicado: (2013)

Combined targeting of MDM2 and CDK4 is synergistic in dedifferentiated liposarcomas
por: Laroche-Clary, Audrey, et al.
Publicado: (2017)

Cracking the riddle of dedifferentiated liposarcoma: is EV-MDM2 a key?
por: Casadei, Lucia, et al.
Publicado: (2020)

Challenging dedifferentiated liposarcoma identified by MDM2-amplification, a report of two cases
por: Lokka, Suvi, et al.
Publicado: (2014)

Hypopharyngeal Dedifferentiated Liposarcoma in the MDM2 Era: A Case Report and Short Review
por: Wanes, Peter, et al.
Publicado: (2020)

Fine needle aspiration biopsy diagnosis of dedifferentiated liposarcoma: Cytomorphology and MDM2 amplification by FISH
por: Al-Maghraby, Hatem Q., et al.
Publicado: (2010)

Novel Therapeutic Insights in Dedifferentiated Liposarcoma: A Role for FGFR and MDM2 Dual Targeting
por: Dadone-Montaudié, Bérengère, et al.
Publicado: (2020)

Rare Aggressive Behavior of MDM2-Amplified Retroperitoneal Dedifferentiated Liposarcoma, with Brain, Lung and Subcutaneous Metastases
por: Ben Salha, Imen, et al.
Publicado: (2016)

Retroperitoneal dedifferentiated liposarcoma with osteosarcomatous dedifferentiation
por: Nguyen, Vinh N., et al.
Publicado: (2015)

MDM2 antagonists synergize with PI3K/mTOR inhibition in well-differentiated/dedifferentiated liposarcomas
por: Laroche, Audrey, et al.
Publicado: (2017)

Detection of MDM2 amplification by shallow whole genome sequencing of cell-free DNA of patients with dedifferentiated liposarcoma
por: Przybyl, Joanna, et al.
Publicado: (2022)

Primary dedifferentiated liposarcoma of the breast: A case report
por: Shrestha, Suraj, et al.
Publicado: (2022)

Giant Retroperitoneal Mucinous Tumor Supportively Diagnosed as a Dedifferentiated Liposarcoma by Fluorescence In Situ Hybridization of MDM2 Gene
por: Naiki, Taku, et al.
Publicado: (2011)

Dedifferentiated liposarcoma of the adult male breast
por: Raj, Sean D., et al.
Publicado: (2015)

Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation
por: Gaughan, Luke, et al.
Publicado: (2005)

Myogenic dedifferentiation is associated with poor outcomes in retroperitoneal dedifferentiated liposarcomas
por: Dorian Yarih, Garcia-Ortega, et al.
Publicado: (2021)

Overexpression of Replication-Dependent Histone Signifies a Subset of Dedifferentiated Liposarcoma with Increased Aggressiveness
por: Yoo, Yongjin, et al.
Publicado: (2021)

Dedifferentiated liposarcoma of the retroperitoneum with osteosarcomatous component
por: Sun, Wenbin, et al.
Publicado: (2012)

Dedifferentiated Paratesticular Liposarcoma with Osseous Metaplasia
por: Chondros, Kostas, et al.
Publicado: (2015)

Scattered genomic amplification in dedifferentiated liposarcoma
por: Mandahl, Nils, et al.
Publicado: (2017)

Multifocal Dedifferentiated Liposarcoma of the Jejunal Mesentery
por: Khanduri, Archana, et al.
Publicado: (2021)

Correction to ‘Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation’
por: Gaughan, Luke, et al.
Publicado: (2021)

BMP2/BMPR1A is linked to tumour progression in dedifferentiated liposarcomas
por: O’Neill, Hannah L., et al.
Publicado: (2016)

Preclinical evaluation of potential therapeutic targets in dedifferentiated liposarcoma
por: Hanes, Robert, et al.
Publicado: (2016)

Beyond targeting amplified MDM2 and CDK4 in well differentiated and dedifferentiated liposarcomas: From promise and clinical applications towards identification of progression drivers
por: Cassinelli, Giuliana, et al.
Publicado: (2022)

An unusual case of primary colonic dedifferentiated liposarcoma()
por: Türkoğlu, Mehmet Akif, et al.
Publicado: (2013)

Dedifferentiated Liposarcoma Occurring in the Right Pulmonary Hilum
por: Koike, Hirofumi, et al.
Publicado: (2017)

A case of dedifferentiated liposarcoma of the heart and stomach
por: Hisata, Yoichi, et al.
Publicado: (2017)

Dedifferentiated liposarcoma of the gallbladder: first reported case
por: da Costa, Adriano Carneiro, et al.
Publicado: (2018)

Adipogenesis induces growth inhibition of dedifferentiated liposarcoma
por: Kim, Yu Jin, et al.
Publicado: (2019)

Dedifferentiated spermatic cord liposarcoma with macroscopic ossification
por: Ando, Takashi, et al.
Publicado: (2018)

Integrated exome and RNA sequencing of dedifferentiated liposarcoma
por: Hirata, Makoto, et al.
Publicado: (2019)

Telomere as a Therapeutic Target in Dedifferentiated Liposarcoma
por: Alessandrini, Irene, et al.
Publicado: (2022)

Giant Dedifferentiated Gastric Liposarcoma: Largest to Date
por: Baker, William G, et al.
Publicado: (2023)

MDM2 Antagonists Induce a Paradoxical Activation of Erk1/2 through a P53-Dependent Mechanism in Dedifferentiated Liposarcomas: Implications for Combinatorial Strategies
por: Roy, Shomereeta, et al.
Publicado: (2020)

Fluorescence In Situ Hybridization for MDM2 Amplification as a Routine Ancillary Diagnostic Tool for Suspected Well-Differentiated and Dedifferentiated Liposarcomas: Experience at a Tertiary Center
por: Thway, Khin, et al.
Publicado: (2015)

Co-expression of MDM2 and CDK4 in transformed human mesenchymal stem cells causes high-grade sarcoma with a dedifferentiated liposarcoma-like morphology
por: Kim, Yu Jin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gqm5opqfc651har0m6h2udqhjo